ENZO BIOCHEM INC
DelistedCIK 316253fmd_1ZR3HWMXS4G50KKYRGB0YQXSNTManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Aug 01, 2009 to Apr 30, 2025, 63 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 98 | 103 | 105 | 101 | 81 | 76 | 118 | 33 | 31 | 32 |
| Cost of revenue | 15 | 14 | 59 | 60 | 58 | 52 | 64 | 19 | 18 | 17 |
| Net interest income | – | – | – | 1 | 1 | 0 | 0 | – | – | – |
| Gross profit | 82 | 88 | 46 | 41 | 23 | 24 | 54 | 13 | 13 | 15 |
| Research and development | 3 | 4 | 3 | 3 | 3 | 4 | 3 | 2 | 4 | 3 |
| Selling, general and administrative | 41 | 44 | 44 | 44 | 44 | 43 | 45 | 23 | 27 | 22 |
| Operating income | (1) | 47 | (3) | (12) | 2 | (30) | 1 | (17) | (25) | (12) |
| Interest expense | – | – | – | – | – | – | – | (0) | 1 | 0 |
| Interest and investment income | (0) | (0) | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 4 |
| Other non-operating income (expense) | 0 | 0 | 0 | 0 | 0 | 0 | 7 | (1) | 0 | 0 |
| Income before taxes | (2) | 46 | (3) | (11) | 2 | (29) | 8 | (20) | (25) | (10) |
| Income tax expense | (0) | 1 | 0 | (1) | – | – | – | – | – | – |
| Net income from continuing operations | (2) | 45 | (3) | (10) | – | – | – | (20) | (25) | (10) |
| Net income | (2) | 45 | (3) | (10) | 2 | (29) | 8 | (18) | 20 | (26) |